Ubrolexin
Broad Spectrum Intramammary Treatment for Clinical Mastitis
CompositionEach 10g Intramammary syringe contains Cefalexin (as monohydrate)- 200mg, Kanamycin ( as monosulphate)-100000 IU Indication/ RecommendationTreatment of Clinical Mastitis in lactating cows caused by bacteria susceptible to the combination of Cefalexen & Kanamycin such has Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, E.coli & CNS Dosage & AdministrationTreat the infected quarter’s with 1 syringe/udder quarter for 2 consecutive days at 24 hours interval PresentationBox of 20 Tubes with teat wipes |
![]() |